Literature DB >> 24725662

Report from a consensus meeting: response to chemoradiotherapy in rectal cancer - predictor of cure and a crucial new choice for the patient: on behalf of the Champalimaud 2014 Faculty for 'Rectal cancer: when NOT to operate'.

Richard John Heald1, Geerard Beets, Carlos Carvalho.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24725662     DOI： 10.1111/codi.12627

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN： 1462-8910            Impact factor:   3.788


× No keyword cloud information.
  8 in total

Review 1.  Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.

Authors:  Irshad Shaikh; Alan Askari; Suzana Ourû; Janindra Warusavitarne; Thanos Athanasiou; Omar Faiz
Journal:  Int J Colorectal Dis       Date:  2014-11-04       Impact factor: 2.571

2.  [Tumor regression after neoadjuvant short-term irradiation for rectal cancer].

Authors:  P Mroczkowski; C J Bruns
Journal:  Chirurg       Date:  2015-09       Impact factor: 0.955

3.  Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence.

Authors:  Karen Benezery; Lucile Montagne; Ludovic Evesque; Renaud Schiappa; Jean-Michel Hannoun-Levi; Eric Francois; Brice Thamphya; Jean-Pierre Gerard
Journal:  Clin Transl Radiat Oncol       Date:  2020-07-06

4.  Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?

Authors:  Clotilde Debove; Nathalie Guedj; Ecoline Tribillon; Léon Maggiori; Magaly Zappa; Yves Panis
Journal:  Int J Colorectal Dis       Date:  2016-03-07       Impact factor: 2.571

Review 5.  Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.

Authors:  Mark Lawler; Deborah Alsina; Richard A Adams; Annie S Anderson; Gina Brown; Nicola S Fearnhead; Stephen W Fenwick; Stephen P Halloran; Daniel Hochhauser; Mark A Hull; Viktor H Koelzer; Angus G K McNair; Kevin J Monahan; Inke Näthke; Christine Norton; Marco R Novelli; Robert J C Steele; Anne L Thomas; Lisa M Wilde; Richard H Wilson; Ian Tomlinson
Journal:  Gut       Date:  2018-01       Impact factor: 23.059

Review 6.  International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.

Authors:  Emmanouil Fokas; Ane Appelt; Alexandra Gilbert; David Sebag-Montefiore; Claus Rödel; Robert Glynne-Jones; Geerard Beets; Rodrigo Perez; Julio Garcia-Aguilar; Eric Rullier; J Joshua Smith; Corrie Marijnen; Femke P Peters; Maxine van der Valk; Regina Beets-Tan; Arthur S Myint; Jean-Pierre Gerard; Simon P Bach; Michael Ghadimi; Ralf D Hofheinz; Krzysztof Bujko; Cihan Gani; Karin Haustermans; Bruce D Minsky; Ethan Ludmir; Nicholas P West; Maria A Gambacorta; Vincenzo Valentini; Marc Buyse; Andrew G Renehan
Journal:  Nat Rev Clin Oncol       Date:  2021-08-04       Impact factor: 66.675

7.  Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.

Authors:  E J A Morris; P J Finan; K Spencer; I Geh; A Crellin; P Quirke; J D Thomas; S Lawton; R Adams; D Sebag-Montefiore
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-02-28       Impact factor: 4.126

8.  A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Authors:  Nick J Battersby; Mit Dattani; Sheela Rao; David Cunningham; Diana Tait; Richard Adams; Brendan J Moran; Shelize Khakoo; Paris Tekkis; Shahnawaz Rasheed; Alex Mirnezami; Philip Quirke; Nicholas P West; Iris Nagtegaal; Irene Chong; Anguraj Sadanandam; Nicola Valeri; Karen Thomas; Michelle Frost; Gina Brown
Journal:  Trials       Date:  2017-08-29       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.